Life Science Company News

Reset
Results 61 - 80 out of 500 displayed.
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Algernon NeuroScience Announces Successful Completion of Highest Planned Single Dose in DMT Phase 1 Trial; Accelerates Plans for Phase 2 Stroke and TBI Studies

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Algernon Pharmaceuticals Inc.

RS BioTherapeutics Appoints Michelle L. Shuffett, MD as SVP of Medical and Scientific Affairs

Read more ››
By: GlobeNewswire - 05 Jun 2023

Akero Therapeutics’ Phase 2b SYMMETRY Cohort D Study Met Safety & Tolerability Endpoints and Showed Adding EFX to GLP-1 Therapy Significantly Improved Non-Invasive Markers of NASH-Related Disease

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Akero Therapeutics, Inc.

Grace Breeding Announces Results from its NFT Bio-Fertilizer Field Trial in Corn Plants Conducted in Brazil Confirming Previous Greenhouse Results

Read more ››
By: GlobeNewswire - 05 Jun 2023

Krystal Biotech to Present at Upcoming Investor Conferences

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Krystal Biotech, Inc.

NewAmsterdam Pharma Announces Positive Topline Results from Phase 2b Dose-Finding Trial Evaluating Obicetrapib in Japanese Patients

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  NewAmsterdam Pharma B.V.

Avadel Pharmaceuticals Announces U.S. Commercial Launch of LUMRYZ™ (sodium oxybate) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Adults Living with Narcolepsy

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Avadel Pharmaceuticals plc

Tonix Pharmaceuticals Announces Presentation of Data Supporting Development of Racemic and Single (S)-Isomer Tianeptine, Plastogen Anti-Depressants, at the American Society of Clinical Psychopharmacology Meeting

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Tonix Pharmaceuticals Holding Corp.

Ractigen Therapeutics Announces Dosing of First Patient in First in Human Trial of RAG-17 for the Treatment of SOD1-ALS

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Ractigen Therapeutics

Agios to Present at the Goldman Sachs Global Healthcare Conference on June 15, 2023

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Agios Pharmaceuticals, Inc.

Prenetics Announces First Quarter 2023 Financial Results

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Prenetics Global Ltd.

ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  ANeuroTech

EyePoint Pharmaceuticals Completes Enrollment in Phase 2 PAVIA Clinical Trial of EYP-1901 in Non-Proliferative Diabetic Retinopathy

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  EyePoint Pharmaceuticals, Inc.

NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Lotus Pharmaceutical Co., Ltd.

Immodulon Appoints Experienced Clinical and Medical Affairs Executive Josefine Roemmler-Zehrer, MD, Associate Professor, as Chief Medical Officer

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Immodulon Therapeutics Ltd.

Domain Therapeutics announces nomination of first-in-class PAR2 NAM candidate, DT-9045, to unlock new cancer treatment possibilities

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Domain Therapeutics S.A | Domain Therapeutics NA Inc

Arvinas to Participate in Upcoming Investor Conferences

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Arvinas Inc.

Ocugen, Inc. Announces Business Advisory Board

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Ocugen, Inc.

Chimeric Therapeutics To Attend BIO International Convention

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Chimeric Therapeutics Ltd

Aptose Biosciences Provides Update on Reverse Stock Split

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Aptose Biosciences Inc.
Results 61 - 80 out of 500 displayed.
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »